You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders
|
|---|---|
| Published in |
Frontiers in Pharmacology, February 2019
|
| DOI | 10.3389/fphar.2019.00099 |
| Pubmed ID | |
| Authors |
Stacey L. Aldrich, Ethan A. Poweleit, Cynthia A. Prows, Lisa J. Martin, Jeffrey R. Strawn, Laura B. Ramsey |
X Demographics
The data shown below were collected from the profiles of 20 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 13 | 65% |
| Canada | 1 | 5% |
| Switzerland | 1 | 5% |
| Unknown | 5 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 11 | 55% |
| Scientists | 6 | 30% |
| Practitioners (doctors, other healthcare professionals) | 3 | 15% |
Mendeley readers
The data shown below were compiled from readership statistics for 107 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 107 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 14 | 13% |
| Student > Bachelor | 12 | 11% |
| Researcher | 10 | 9% |
| Student > Ph. D. Student | 10 | 9% |
| Other | 8 | 7% |
| Other | 19 | 18% |
| Unknown | 34 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 23 | 21% |
| Pharmacology, Toxicology and Pharmaceutical Science | 14 | 13% |
| Biochemistry, Genetics and Molecular Biology | 13 | 12% |
| Nursing and Health Professions | 3 | 3% |
| Agricultural and Biological Sciences | 3 | 3% |
| Other | 12 | 11% |
| Unknown | 39 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 December 2019.
All research outputs
#2,497,099
of 24,593,555 outputs
Outputs from Frontiers in Pharmacology
#1,036
of 18,619 outputs
Outputs of similar age
#55,563
of 357,995 outputs
Outputs of similar age from Frontiers in Pharmacology
#34
of 369 outputs
Altmetric has tracked 24,593,555 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 18,619 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 357,995 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 369 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.